Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles

Nanomedicine is a potential provider of novel therapeutic and diagnostic routes of treatment. Considering the development of multidrug resistance in pathogenic bacteria and the commonness of cancer, novel approaches are being sought for the safe and efficient synthesis of new nanoparticles, which ha...

Full description

Bibliographic Details
Main Authors: Piotr Roszczenko, Olga Klaudia Szewczyk, Robert Czarnomysy, Krzysztof Bielawski, Anna Bielawska
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/11/2286
_version_ 1797466811842691072
author Piotr Roszczenko
Olga Klaudia Szewczyk
Robert Czarnomysy
Krzysztof Bielawski
Anna Bielawska
author_facet Piotr Roszczenko
Olga Klaudia Szewczyk
Robert Czarnomysy
Krzysztof Bielawski
Anna Bielawska
author_sort Piotr Roszczenko
collection DOAJ
description Nanomedicine is a potential provider of novel therapeutic and diagnostic routes of treatment. Considering the development of multidrug resistance in pathogenic bacteria and the commonness of cancer, novel approaches are being sought for the safe and efficient synthesis of new nanoparticles, which have multifaceted applications in medicine. Unfortunately, the chemical synthesis of nanoparticles raises justified environmental concerns. A significant problem in their widespread use is also the toxicity of compounds that maintain nanoparticle stability, which significantly limits their clinical use. An opportunity for their more extensive application is the utilization of plants, fungi, and bacteria for nanoparticle biosynthesis. Extracts from natural sources can reduce metal ions in nanoparticles and stabilize them with non-toxic extract components.
first_indexed 2024-03-09T18:44:58Z
format Article
id doaj.art-596f407f848a4081b44348fb7485bfb8
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T18:44:58Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-596f407f848a4081b44348fb7485bfb82023-11-24T06:19:41ZengMDPI AGPharmaceutics1999-49232022-10-011411228610.3390/pharmaceutics14112286Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal NanoparticlesPiotr Roszczenko0Olga Klaudia Szewczyk1Robert Czarnomysy2Krzysztof Bielawski3Anna Bielawska4Department of Biotechnology, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, PolandDepartment of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, PolandDepartment of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, PolandDepartment of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, PolandDepartment of Biotechnology, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, PolandNanomedicine is a potential provider of novel therapeutic and diagnostic routes of treatment. Considering the development of multidrug resistance in pathogenic bacteria and the commonness of cancer, novel approaches are being sought for the safe and efficient synthesis of new nanoparticles, which have multifaceted applications in medicine. Unfortunately, the chemical synthesis of nanoparticles raises justified environmental concerns. A significant problem in their widespread use is also the toxicity of compounds that maintain nanoparticle stability, which significantly limits their clinical use. An opportunity for their more extensive application is the utilization of plants, fungi, and bacteria for nanoparticle biosynthesis. Extracts from natural sources can reduce metal ions in nanoparticles and stabilize them with non-toxic extract components.https://www.mdpi.com/1999-4923/14/11/2286metal nanoparticlesgreen synthesisanticancer activityantibacterial activity
spellingShingle Piotr Roszczenko
Olga Klaudia Szewczyk
Robert Czarnomysy
Krzysztof Bielawski
Anna Bielawska
Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles
Pharmaceutics
metal nanoparticles
green synthesis
anticancer activity
antibacterial activity
title Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles
title_full Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles
title_fullStr Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles
title_full_unstemmed Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles
title_short Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles
title_sort biosynthesized gold silver palladium platinum copper and other transition metal nanoparticles
topic metal nanoparticles
green synthesis
anticancer activity
antibacterial activity
url https://www.mdpi.com/1999-4923/14/11/2286
work_keys_str_mv AT piotrroszczenko biosynthesizedgoldsilverpalladiumplatinumcopperandothertransitionmetalnanoparticles
AT olgaklaudiaszewczyk biosynthesizedgoldsilverpalladiumplatinumcopperandothertransitionmetalnanoparticles
AT robertczarnomysy biosynthesizedgoldsilverpalladiumplatinumcopperandothertransitionmetalnanoparticles
AT krzysztofbielawski biosynthesizedgoldsilverpalladiumplatinumcopperandothertransitionmetalnanoparticles
AT annabielawska biosynthesizedgoldsilverpalladiumplatinumcopperandothertransitionmetalnanoparticles